Heterogeneous clinicopathological features of intraductal carcinoma of the prostate: A comparison between 'precursor-like' and 'regular type' lesions

International Journal of Clinical and Experimental Pathology

Volumn 7, Issue 5, 2014, Pages 2518-2526

  Miyai, Kosuke ^a   Divatia, Mukul K ^a   Shen, Steven S ^a,c   Miles, Brian J ^b   Ayala, Alberto G ^a,c   Ro, Jae Y ^a,c  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b HOUSTON METHODIST HOSPITAL   (United States)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

High grade prostatic intraepithelial neoplasia; Intraductal carcinoma of prostate; Prostate

Indexed keywords

KALLIKREIN; KALLIKREIN-RELATED PEPTIDASE 3, HUMAN; PROSTATE SPECIFIC ANTIGEN;

AGED; BIOPSY; BLOOD; CANCER GRADING; CANCER STAGING; CARCINOMA, DUCTAL; CARCINOMA, INTRADUCTAL, NONINFILTRATING; CHEMISTRY; COMPARATIVE STUDY; DISEASE FREE SURVIVAL; HUMAN; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; LYMPH NODE METASTASIS; MALE; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; PATHOLOGY; PREDICTIVE VALUE; PROPORTIONAL HAZARDS MODEL; PROSTATECTOMY; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROSTATIC NEOPLASMS; RISK FACTOR; SECONDARY; TIME; TREATMENT OUTCOME; TUMOR INVASION;

AGED; BIOPSY; CARCINOMA, DUCTAL; CARCINOMA, INTRADUCTAL, NONINFILTRATING; DISEASE-FREE SURVIVAL; HUMANS; IMMUNOHISTOCHEMISTRY; KALLIKREINS; KAPLAN-MEIER ESTIMATE; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM GRADING; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROSTATIC NEOPLASMS; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84902477261     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. McNeal JE and Yemoto CE. Spread of adenocarcinoma within prostatic ducts and acini. Morphologic and clinical correlations. Am J Surg Pathol 1996; 20: 802-814.
2. Cohen RJ, McNeal JE and Baillie T. Patterns of differentiation and proliferation in intraductal carcinoma of the prostate: significance for cancer progression. Prostate 2000; 43: 11-19.
3. Rhamy RH, Buchanan RD and Spalding MJ. Intraductal carcinoma of the prostate gland. J Urol 1973; 109: 457-460.
4. Catalona WJ, Kadmon D and Martin SA. Surgical considerations in treatment of intraductal carcinoma of the prostate. J Urol 1978; 120: 259-261.
5. Henry PC and Evans AJ. Intraductal carcinoma of the prostate: a distinct histopathological entity with important prognostic implications. J Clin Pathol 2009; 62: 579-583.
6. Guo CC and Epstein JI. Intraductal carcinoma of the prostate on needle biopsy: Histologic features and clinical significance. Mod Pathol 2006; 19: 1528-1535.
7. Robinson BD and Epstein JI. Intraductal carcinoma of the prostate without invasive carcinoma on needle biopsy: emphasis on radical prostatectomy findings. J Urol 2010; 184: 1328-1333.
8. Clouston D and Bolton D. In situ and intraductal epithelial proliferations of prostate: definitions and treatment implication. Part 2: intraductal carcinoma and ductal adenocarcinoma of prostate. BJU Int 2012; 110: 22-24.
9. Bonkhoff H, Wheeler TM, van der Kwast TH, Magi-Galluzzi C, Montironi R and Cohen RJ. Intraductal carcinoma of the prostate: precursor or aggressive phenotype of prostate cancer? Prostate 2013; 73: 442-448.
10. Bostwick DG, Liu L, Brawer MK and Qian J. High-grade prostatic intraepithelial neoplasia. Rev Urol 2004; 6: 171-179.
11. Ribeiro FR, Diep CB, Jerónimo C, Henrique R, Lopes C, Eknaes M, Lingjaerde OC, Lothe RA and Teixeira MR. Statistical dissection of genetic pathways involved in prostate carcinogenesis. Genes Chromosomes Cancer 2006; 45: 154-163.
12. Schoenfield L, Jones JS, Zippe CD, Reuther AM, Klein E, Zhou M and Magi-Galluzzi C. The incidence of high-grade prostatic intraepithelial neoplasia and atypical glands suspicious for carcinoma on first-time saturation needle biopsy, and the subsequent risk of cancer. BJU Int 2007; 99: 770-774.
13. Dawkins HJ, Sellner LN, Turbett GR, Thompson CA, Redmond SL, McNeal JE and Cohen RJ. Distinction between intraductal carcinoma of the prostate (IDC-P), high-grade dysplasia (PIN), and invasive prostatic adenocarcinoma, using molecular markers of cancer progression. Prostate 2000; 44: 265-270.
14. Bettendorf O, Schmidt H, Staebler A, Grobholz R, Heinecke A, Boecker W, Hertle L and Semjonow A. Chromosomal imbalances, loss of heterozygosity, and immunohistochemical ex pression of TP53, RB1, and PTEN in intraductal cancer, intraepithelial neoplasia, and invasive adenocarcinoma of the prostate. Genes Chromosomes Cancer 2008; 47: 565-572.
15. Han B, Suleman K, Wang L, Siddiqui J, Sercia L, Magi-Galluzzi C, Palanisamy N, Chinnaiyan AM, Zhou M, and Shah RB. ETS gene aberrations in atypical cribriform lesions of the prostate:Implications for the distinction between intraductal carcinoma of the prostate and cribriform high-grade prostatic intraepithelial neoplasia. Am J Surg Pathol 2010; 34: 478-485.
16. McNeal JE, Reese JH, Redwine EA, Freiha FS and Stamey TA. Cribriform adenocarcinoma of the prostate. Cancer 1986; 58: 1714-1719.
17. McNeal JE, Villers A, Redwine EA, Freiha FS, Stamey TA. Microcarcinoma in the prostate: its association with duct-acinar dysplasia. Hum Pathol 1991; 22: 644-652.
18. McNeal JE. Prostatic microcarcinomas in relation to cancer origin and the evolution to clinical cancer. Cancer 1993; 71: 984-991.
19. Iwata T, Schultz D, Hicks J, Hubbard GK, Mutton LN, Lotan TL, Bethel C, Lotz MT, Yegnasubramanian S, Nelson WG, Dang CV, Xu M, Anele U, Koh CM, Bieberich CJ and De Marzo AM. MYC overexpression induces prostatic intraepithelial neoplasia and loss of Nkx3.1 in mouse luminal epithelial cells. PLoS One 2010; 5: e9427.
20. Cohen RJ, Shannon BA and Weinstein SL. Intraductal carcinoma of the prostate gland with transmucosal spread to the seminal vesicle: a lesion distinct from high-grade prostatic intraepithelial neoplasia. Arch Pathol Lab Med 2007; 131: 1122-1125.
21. Cookson MS, Aus G, Burnett AL, Canby-Hagino ED, D'Amico AV, Dmochowski RR, Eton DT, Forman JD, Goldenberg SL, Hernandez J, Higano CS, Kraus SR, Moul JW, Tangen C, Thrasher JB and Thompson I. Variation in the definition of biochemical recurrence in patients treated for localized prostate cancer: the American Urological Association Prostate Guidelines for Localized Prostate Cancer Update Panel report and recommendations for a standard in the reporting of surgical outcomes. J Urol 2007; 177: 540-545.
22. Critz FA. A standard definition of disease freedom is needed for prostate cancer: undetectable prostate specific antigen compared with the American Society of Therapeutic Radiology and Oncology consensus definition. J Urol 2002; 167: 1310-1313.
23. Bostwick DG and Meiers I. Neoplasm of the prostate. In: Bostwick DG, Cheng L, Eds. Urologic surgical pathology. New York: Elsevier; 2008. pp: 476.
24. Epstein JI, Allsbrook WC, Amin MB and Egevad LL. The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma. Am J Surg Pathol 2005; 29: 1228-1242.
25. Epstein JI. An update of the Gleason grading system. J Urol 2010; 183: 433-440.
26. Chang SS, McKiernan JM, Amin M, Bochner BH, Campbell S and Gospodarowicz MK. American Joint Committee on Cancer. Prostate, In: Edge SB, Byrd DR, Compton CC, Friz AG, Greene FL and Trotti A, Eds. AJCC Cancer Staging Manual. 7th ed. New York: Springer; 2010. pp: 457-464.
27. Cohen RJ, Wheeler TM, Bonkhoff H and Rubin MA. A proposal on the identification, histologic reporting, and implications of intraductal prostatic carcinoma. Arch Pathol Lab Med 2007; 131: 1103-1109.
28. Shah RB, Magi-Galluzzi C, Han B and Zhou M. Atypical cribriform lesions of the prostate: relationship to prostatic carcinoma and implication for diagnosis in prostate biopsies. Am J Surg Pathol 2010; 34: 470-477.
29. Shah RB and Zhou M. Atypical cribriform lesions of the prostate: clinical significance, differential diagnosis and current concept of intraductal carcinoma of the prostate. Adv Anat Pathol 2012; 19: 270-278.
30. Roberts JA, Zhou M, Park YW and Ro JY. Intraductal Carcinoma of Prostate: A Comprehensive and Concise Review. Korean J Pathol 2013; 47: 307-315.
31. Horn LC, Meinel A, Handzel R and Einenkel J. Histopathology of endometrial hyperplasia and endometrial carcinoma: an update. Ann Diagn Pathol 2007; 11: 297-311.
32. Burstein HJ, Polyak K, Wong JS, Lester SC and Kaelin CM. Ductal carcinoma in situ of the breast. N Engl J Med 2004; 350: 1430-1441.